126 related articles for article (PubMed ID: 35550834)
1. Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology.
Reiswich V; Akdeniz G; Lennartz M; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Uhlig R; Hinsch A; Kind S; Jacobsen F; Möller K; Steurer S; Minner S; Burandt E; Marx AH; Lebok P; Krech T; Dum D
Hum Pathol; 2022 Aug; 126():108-120. PubMed ID: 35550834
[TBL] [Abstract][Full Text] [Related]
2. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Kaczmarek K; Plage H; Furlano K; Hofbauer S; Weinberger S; Ralla B; Franz A; Fendler A; de Martino M; Roßner F; Schallenberg S; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Weischenfeldt J; Klatte T; Schlomm T; Horst D; Zecha H
Int Urol Nephrol; 2024 Feb; 56(2):499-508. PubMed ID: 37777995
[TBL] [Abstract][Full Text] [Related]
3. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
Reiswich V; Könemann S; Lennartz M; Höflmayer D; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Kind S; Jacobsen F; Steurer S; Minner S; Büscheck F; Burandt E; Marx AH; Lebok P; Krech T
Pathol Res Pract; 2022 Sep; 237():154028. PubMed ID: 35872365
[TBL] [Abstract][Full Text] [Related]
4. Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue.
Finch JL; Miller J; Aspinall JO; Cowled PA
Int J Cancer; 1999 Feb; 80(4):533-8. PubMed ID: 9935153
[TBL] [Abstract][Full Text] [Related]
5. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
Leivo MZ; Elson PJ; Tacha DE; Delahunt B; Hansel DE
Pathology; 2016 Oct; 48(6):543-9. PubMed ID: 27594510
[TBL] [Abstract][Full Text] [Related]
6. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
7. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract][Full Text] [Related]
8. Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.
Lennartz M; Atug D; Dwertmann Rico S; Reiswich V; Viehweger F; Büscheck F; Kluth M; Hube-Magg C; Hinsch A; Bernreuther C; Sauter G; Burandt E; Marx AH; Krech T; Simon R; Minner S; Clauditz TS; Jacobsen F; Lebok P; Gorbokon N; Möller K; Steurer S; Fraune C
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292206
[TBL] [Abstract][Full Text] [Related]
9. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
Völkel C; De Wispelaere N; Weidemann S; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Krech RH; Dum D; Krech T; Marx AH; Simon R; Burandt E; Menz A
Virchows Arch; 2022 Feb; 480(2):433-447. PubMed ID: 34559291
[TBL] [Abstract][Full Text] [Related]
11. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
[TBL] [Abstract][Full Text] [Related]
12. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
13. Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors.
Reiswich V; Gorbokon N; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Wittmer C; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Clauditz T; Krech T
J Pathol Clin Res; 2021 Nov; 7(6):577-589. PubMed ID: 34363325
[TBL] [Abstract][Full Text] [Related]
14. Utility of uroplakin II expression as a marker of urothelial carcinoma.
Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
[TBL] [Abstract][Full Text] [Related]
15. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE
Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease.
Choudhary D; Hegde P; Voznesensky O; Choudhary S; Kopsiaftis S; Claffey KP; Pilbeam CC; Taylor JA
Urol Oncol; 2015 Sep; 33(9):387.e17-27. PubMed ID: 25618296
[TBL] [Abstract][Full Text] [Related]
18. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
Wang FH; Ma XJ; Xu D; Luo J
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases.
Davick JJ; Frierson HF; Smolkin M; Gru AA
Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606
[TBL] [Abstract][Full Text] [Related]
20. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
